Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Merzig – page 2

20 clinical trials in Merzig, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Merzig at a glance
20
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Merzig

Open in trial search

Hidradenitis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:SODIUM BITUMINOSULFONATE DRY SUBSTANCE
  • Sponsor:Ichthyol-Gesellschaft Cordes Hermanni & Co. GmbH & Co. KG
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac Sodium
  • Sponsor:Almirall S.A.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Hidradenitis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Hidradenitis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Merzig

What the registry says about research in the country

01 Hidradenitis Suppurativa Research

Multiple groundbreaking studies focusing on Hidradenitis Suppurativa (HS), evaluating novel therapeutic approaches including spesolimab and povorcitinib for moderate to severe cases. These trials aim to establish long-term safety profiles and treatment efficacy for patients who haven't responded to conventional therapies.

  • Novel drug evaluations
  • Long-term safety assessments
  • Treatment-resistant cases

Comprehensive research focusing on both adult and adolescent populations.

02 Dermatological Conditions

Important clinical research addressing various skin conditions, including actinic keratosis and plaque psoriasis. Studies are evaluating new topical treatments and comparing their effectiveness with existing therapies.

  • Skin cancer prevention
  • Comparative treatment studies
  • Advanced therapeutic options

Focus on innovative approaches for treating chronic skin conditions.

03 Atopic Dermatitis Studies

Clinical investigations examining the efficacy of methylprednisolone aceponate formulations for mild to moderate atopic dermatitis. These studies compare different ointment preparations to optimize treatment outcomes.

  • Topical treatment comparison
  • Vehicle-controlled studies
  • Safety assessments

Research aimed at improving therapeutic options for atopic dermatitis patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.